Paxalisib | Interleukin Related interleukin-related.com

Product Name :
Paxalisib

Search keywords :
Paxalisib

drugId :
null

Target Vo:
PI3-kinase class I

Target Vo Short Name :
Class I PI3K

Moa_Name:
PI3-kinase class I inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Brain Neoplasms

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glutathione Peroxidase 1 Antibody (YA404)
Alexa Fluor® 405-conjugated AffiniPure Goat Anti-Mouse IgG H&L
GSDME Antibody: GSDME Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to GSDME. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts